Ong, Kokmen, III. R.

HRN: 24-26-20  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2023
CEFUROXIME 750MG (VIAL)
12/18/2023
12/25/2023
IV
750
Q8
Dengue Fever With WS; PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: